Kratom News logo
FDA-funded 2026 study finds dried kratom leaf safe and well tolerated in a 116-person human trial

Here’s some research news worth celebrating: a landmark kratom safety study published in early 2026 — funded in part by the FDA itself — found that dried kratom leaf was safe and well tolerated in a rigorous human trial. For a plant that’s spent years under a cloud of uncertainty, this is exactly the kind of solid, science-backed good news the community has been waiting for. 🌿

At Kratom News, we love it when the data catches up with what millions of responsible users have long experienced. So let’s break down what this kratom safety study actually found, why it matters, and how the bigger picture is brightening in 2026.

FDA-FUNDED HUMAN TRIAL · 2026
116 volunteers
47 days · safe & well tolerated · no serious adverse events

🔬 What the Kratom Safety Study Found

The new kratom safety study, published in Therapeutic Drug Monitoring in January 2026, was no small effort. It was a randomized, double-blind, placebo-controlled, dose-escalation trial — the gold standard of research design — involving 116 healthy volunteers over a 47-day period. Of those, 49 received the active dried kratom leaf product and 67 received a placebo.

The headline result? Researchers concluded that the dried leaf powder was “safe and well tolerated” at the doses tested, with no serious adverse events and no deaths in either group. For anyone who values kratom as part of a wellness routine, having that conclusion come from a carefully controlled, FDA-funded kratom safety study is a genuinely encouraging milestone. When you choose quality whole-leaf products from a trusted vendor like KratomDeal, you’re using the same category of natural dried leaf that researchers studied.

A gold-standard kratom safety study calling the dried leaf “safe and well tolerated” is a milestone years in the making.

116 volunteers: FDA-funded kratom safety study found the leaf safe and well tolerated over 47 days

📈 The Industry Is Growing — and Maturing

The timing of this kratom safety study couldn’t be better, because the market is booming. The global kratom market reached roughly $2.56 billion in 2025 and is projected to climb toward $7.8 billion by 2032 — growth driven by consumers seeking natural wellness options. Just as important, quality is becoming a competitive advantage: more than 45 vendors have now earned American Kratom Association GMP certification, signaling clean sourcing and third-party testing to increasingly savvy buyers.

In other words, demand is rising and standards are rising right along with it. That’s the healthiest kind of growth — and it means finding trustworthy, lab-tested kratom keeps getting easier.

🌎 Keeping It Honest: Research Is Still Growing

Good vibes don’t mean overstating the science. Researchers are clear that large, controlled trials like this one are still relatively few, and more well-designed studies are needed to fully map kratom’s effects. The encouraging takeaway is that this kind of rigorous research is finally happening — and the early, high-quality results are pointing in a reassuring direction. As always, responsible, informed use and buying from reputable vendors is the smart approach.

✅ How to Put This Good News to Work

The practical lesson from the kratom safety study is simple: stick with natural dried-leaf products from vendors who lab-test and label honestly — the same category researchers found safe and well tolerated. For more on how quality standards are evolving, see our coverage of how GMP and KCPA standards make lab-tested kratom easier to find, and how the FDA is drawing a clear line around concentrated 7-OH while protecting the natural leaf.

🌿 Trusted, Lab-Tested Kratom Vendors

Our community’s go-to shops for clean, third-party-tested kratom:

See our full vendor guide: Where to Buy Kratom Online →

The bottom line for 2026: a rigorous, FDA-funded kratom safety study calling the dried leaf safe and well tolerated is a real, science-backed reason for optimism. We’ll keep bringing you the facts and the bright side, every single day.

❓ Kratom Safety Study 2026: Your Questions Answered

What did the 2026 FDA-funded kratom safety study find?
The study, published in Therapeutic Drug Monitoring in January 2026, found dried kratom leaf powder to be safe and well tolerated in 116 healthy volunteers over 47 days, with no serious adverse events in the active or placebo groups.
How was the kratom safety study designed?
It was a randomized, double-blind, placebo-controlled, dose-escalation trial — a rigorous gold-standard design. Of the 116 participants, 49 received the active dried kratom leaf product and 67 received a placebo.
Does this study mean kratom is completely proven safe?
It’s a strong, encouraging result, but researchers note that large controlled trials remain relatively few and more studies are needed. Responsible use and buying lab-tested products from reputable vendors is still the smart approach.
How big is the kratom market in 2026?
The global kratom market reached roughly $2.56 billion in 2025 and is projected to grow toward $7.8 billion by 2032, with quality certification like AKA GMP increasingly driving consumer trust.
How do I choose kratom similar to what was studied?
The study used natural dried leaf powder. Choose whole-leaf products from vendors that publish third-party lab results (a Certificate of Analysis) and follow honest labeling — ideally with AKA GMP certification.

Sources: “Safety and tolerability of dried kratom leaf,” Therapeutic Drug Monitoring, January 2026 (FDA-funded human trial); kratom market growth analyses, 2025–2026; American Kratom Association GMP program.

This article is for informational and news purposes only and is not medical advice. Kratom’s legal status varies by location; always check your local laws.